Search PubMed⌕ Search

Biomedical subjects

Doug Campos-Outcalt

Publications and source records attributed to Doug Campos-Outcalt.

At least 19 recordsLinked to original sources
PubMed2006

Disaster medical response: maximizing your effectiveness.

In the aftermath of Hurricane Katrina, physicians and other health professionals volunteered for deployment to the affected area to provide medical services. The frustrating reality most of them encountered was the incapacity of those in charge to use the number of professional volunteers expressing interest. Untrained volunteers, though well intentioned, are often not that helpful. The immediate needs of a disaster area relate to public health and other safety issues. Until a proper infrastructure is re-established, general medical services cannot be provided. Physician services are most effectively provided in collaboration with, or as part of, an organized local response agency.

Disaster Planning↗
PubMed2006

Are you up to date with new immunization recommendations?

Vaccines are one of the most important and effective tools for protecting the health of the public and family physicians are instrumental in insuring that vaccine recommendations are implemented. With the development of new vaccines come increasingly complex recommendations. Staying current is challenging. This column describes the most recent changes to the immunization schedules made by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC).

Adolescent↗
PubMed2006

The diverse functions of role models across primary care specialties.

BACKGROUND AND OBJECTIVES: This study investigated the relationship of role models to primary care specialty and gathered information on the attributes and functions of role models. METHODS: A questionnaire on medical school experiences and attitudes was administered to primary care graduates from 24 US medical schools. RESULTS: Questionnaires were completed by 1,457 physicians. Sixty-three percent of primary care respondents had a role model. Having a role model was significantly related to current specialty and ethnicity. Respondents most valued their role models' patient relationships. For family medicine and internal medicine graduates, having a role model was related to more contact and more-positive views of faculty in their specialty. Those with a role model reported that primary care was encouraged at their medical school and were more satisfied with their specialty choice. CONCLUSIONS: Role models may be more important to students who are not well represented among medical school faculty, namely women, underrepresented ethnic minorities, and those interested in family medicine. For family medicine graduates, role models function to moderate negative stereotypes. Role models may also make explicit the values of physicians in that specialty, making students more informed when choosing a specialty and as a consequence more satisfied with the decision.

Adult↗
PubMed2006

HIV postexposure prophylaxis: Who should get it?

In most cases, HIV postexposure prophylaxis (PEP) is given only to healthcare workers if the settings make exposure to HIV-infected persons likely. Otherwise, it is usually deemed unnecessary. However, a decision for or against PEP is complicated. Occupational and nonoccupational exposure to HIV can produce fear, anxiety, and stress. Information on the exposure risk is frequently incomplete, the risk of infection is usually low, the degree of protection offered by PEP is not fully defined, and the potential for side effects from the medications is significant. This article distills the Centers for Disease Control and Prevention's most recent guidance on HIV PEP.

Algorithms↗
PubMed2006

The preteen visit: an opportunity for prevention.

All early adolescents should visit a physician at age 11 or 12 years to receive a set of recommended vaccines. Two vaccines are recommended for boys in this age group-quadrivalent meningococcal conjugate vaccine (MCV4) and tetanus toxoid, reduced diphtheria, and acellular pertussis vaccine (Tdap). Three vaccines are recommended for girls--MCV4, Tdap, and human papilloma virus (HPV) vaccine. In addition, 2 doses of varicella vaccine are now recommended before age 5 years; both boys and girls at age 11 or 12 who have received only 1 dose should be given a second.

Adolescent↗
PubMed2005

Family medicine specialty choice and interest in research.

BACKGROUND AND OBJECTIVES: This study investigated interest in research related to declining interest in family medicine by US medical school graduates. METHODS: Twenty-four schools were selected for study based on American Academy of Family Physicians data on the number of their graduates entering family medicine. Data for all graduates in 1997, 1998, and 1999 were obtained from the Association of American Medical Schools matriculation and graduation questionnaires for 23 of 24 schools. RESULTS: Measures of research activity or interest were available on matriculation during medical school and at graduation. All were inversely related to interest in family medicine. Students interested in family medicine were less likely to have selected the field of medicine because of research interests, were less likely to have participated in a research project during medical school, and at graduation were less likely to plan on a career involving research. CONCLUSIONS: Given this pervasive negative relationship between interest in research and interest in family medicine, initiatives intended to increase research within the specialty of family medicine should be evaluated for their effects on student career choices. These initiatives may decrease interest in family medicine among students who don't want to do research but who otherwise might have been interested in family medicine. Conversely, they may increase interest in family medicine among students with research interest, or they may do both.

Biomedical Research↗
PubMed2005

Meningococcal vaccine: New product, new recommendations.

The Centers for Disease Control and Prevention now recommends that all adolescents aged 11 to 12 years receive a quadrivalent, conjugate meningococcal vaccine (MCV-4). With time, universal administration of meningococcal vaccine for this age group will make moot the question of whether entering college freshmen should receive meningococcal vaccine. It should lead to a marked reduction in a potentially catastrophic disease and contribute to the continued decline in morbidity and mortality from bacterial meningitis in the United States, which has largely been due to advances in vaccine technology.

Adolescent↗